|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
��������� |
|
��֬ø |
| ��������������� | |
|
���� |
|
�º� |
| PubMed | |
|
Article by |
|
Article by |
�����������֬ø���о���չ
����, �º�
�Ϻ��ڶ���ҽ��ѧ����ҽԺƤ����, 200003
�������������Ҫ�������²���,����Ҫ��Ⱦ���̲����ߺ��������߹����������Ⱥ.��֬ø��Ϊ�����������һ��DZ�ڵĶ������������ܵ�����.�����������������������֬ø�ļ�⼰�����ʡ����ܵ��²����ƺͷ���ˮƽ���о���չ.
[2] Vidotto V, Sinicco A, Di Fraia D, et al. Phospholipase activity in Cryptococcus neoformans. Mycopathologia, 1996-97, 136(3):119-123.
[3] Chen SC, Muller M, Zhou JZ, et al. Phospholipase activity in Cryptococcus neoformans;a new virulence factor? J Infect Dis, 1997, 175(2):414-420.
[4] Vidotto V, Leone R, Sinicco A, et al. Comparison of phospholipase production in Cryptococcus neoformans isolates from AIDS patients and bird droppings. Mycopathologia, 1998, 142(2):71-76.
[5] Ibrahim AS, Mirbod F, Filler SG, et al. Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect Immun,1995, 63(5):1993-1998.
[6] Chen SC, Wright LC, Golding JC, et al. Purification and characterization of secretory phospholipase B, lysophospholipase and lysophospholipase/transacylase from a virulent strain of the pathogenic fungus Cryptococcus neoformans. Biochem J, 2000, 347(Pt 2):431-439.
[7] Chen SC, Wright LC, Santangelo RT, et al. Identification of extracellular phospholipase B, lysophospholipase, and acyltransferase produced by Cryptococcus neoformans. Infect Immun, 1997, 65(2):405-411.
[8] Santangelo RT, Nouri-Sorkhabi MH, Sorrell TC, et al. Biochemical and functional characterisation of secreted phospholipase activities from Cryptococcus neoformans in their naturally occurring state. J Med Microbiol, 1999, 48(8):731-740.
[9] Cox GM, McDade HC, Chen SC, et al. Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol Microbiol, 2001,39(1):166-175.
[10] Leidich SD, Ibrahim AS, Fu Y, et al. Cloning and disruption of caPLB1, a phospholipase B gene involved in the pathogenicity of Candida albicans. J Biol Chem, 1998, 273(40):26078-26086.
[11] Songer JG. Bacterial phospholipases and their role in virulence. Trends Microbiol, 1997, 5(4):156-161.
[12] Serhan CN, Haeggstrom JZ, Leslie CC. Lipid mediator networks in cell signaling;update and impact of cytokines. FASEB J, 1996, 10(10):1147-1158.
[13] Bryant AE, Stevens DL. Phospholipase C and perfringolysin O from Clostridium perfringens upregulate endothelial cell-leukocyte adherence molecule 1 and intercellular leukocyte adherence molecule 1 expression and induce interleukin-8 synthesis in cultured human umbilical vein endothelial cells. Infect Immun, 1996, 64(1):358-362.
[14] Bunting M, Lorant DE, Bryant AE, et al. Alpha toxin from Clostridium perfringens induces proinflammatory changes in endothelial cells. J Clin Invest, 1997, 100(3):565-574.
[15] Ghannoum MA. Extracellular phospholipases as universal virulence factor in pathogenic fungi. Nippon Ishinkin Gakkai Zasshi, 1998,39(2):55-59.